Our Research Projects
Our research program conducts highly collaborative multidisciplinary clinical and translational research in applying the science of clinical pharmacology, pharmacometrics, pharmacogenetics, and systems pharmacology to develop and implement personalized precision dosing strategies in pediatric and adult patients. Our focused areas include oncology, immunology, inflammatory-related diseases, biologics medications, opioids, and infections. Our overarching goal is to improve health care by integrating quantitative modeling and simulation, digital twin technologies, and advanced analytical and bioinformatic technologies including biosensors and digital health.
Our lab actively collaborates with clinicians and basic and clinical scientists. Our collaborative research projects include:
Clinical Implementation of Model-Informed Precision Dosing (MIPD) in Pediatrics
The goal of precision dosing is to identify optimal dosing regimens that provide adequate therapeutic efficacy with minimal risk of toxicity for each individual patient. The MIPD framework provides a virtual platform to integrate various patient information, (e.g. body size, age, genetic background, and disease characteristics) to evaluate potential clinical scenarios to determine actionable dosing recommendations tailored to each patient’s needs. The MIPD approach also enables the utilization of clinical feedback such as blood concentrations and/or biomarkers to further individualize medications over the course of treatment. In collaboration with various clinicians and clinical scientists, our lab employs MIPD technologies to facilitate therapeutic optimization for various drugs and therapeutic areas, including mTOR inhibitors, anti-inflammatory biologics, immunosuppressive therapies, opioids, and neonatal opioid withdrawal syndrome (NOWS), and anti-infectious drugs.